Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Vancomycin Treatment in Recurrent Primary Sclerosing Cholangitis in Liver Transplant Recipients

NCT03046901 is registered in ClinicalTrials.gov with Ochsner Health System as lead sponsor.

NCT NCT03046901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03046901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Vancomycin Treatment in Recurrent Primary Sclerosing Cholangitis in Liver Transplant Recipients
Lead sponsor
Ochsner Health System
Phase
Not applicable
Overall status
Withdrawn
Start date
December 7, 2016
Completion date
February 25, 2019
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post- orthotopic liver transplantation, primary sclerosing cholangitis